Pharmacokinetics of acetazolamide in healthy volunteers after short- and long-term exposure to high altitude

Journal of Clinical Pharmacology

Volumn 38, Issue 6, 1998, Pages 533-539

  Ritschel, Wolfgang A ^a,d   Paulos, Claudio ^b   Arancibia, Aquiles ^b   Agrawal, Mukul A ^a   Wetzelsberger, Klaus M ^c   Lücker, Peter W ^c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CHILE   (Chile)

^c Institute of Clinical Pharmacology   (Germany)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; PETHIDINE;

ACCLIMATIZATION; ADULT; ALTITUDE DISEASE; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; ERYTHROCYTE VOLUME; HUMAN; HUMAN EXPERIMENT; LONG TERM EXPOSURE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PROTEIN BINDING;

EID: 0031781261     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1998.tb05791.x     Document Type: Article

References (17)

1. Ritschel WA, Paulos C, Arancibia A, Pezzani M, Agrawal MA, Wetzelsberger KM, Lücker PW: Pharmacokinetics of meperidine in healthy volunteers after short-and long-term exposure to high altitude. J Clin Pharmacol 1996;36:610-616.
2. Ritschel WA, Paulos C, Arancibia A, Pezzani M, Agrawal MA, Wetzelsberger KM, Lücker PW: Urinary excretion of meperidine and normeperidine in man upon acute and chronic exposure to high altitude. Methods Find Exp Clin Pharmacol 1996;18:49-53.
3. Hackett PH, Rennie D: Acute mountain sickness. Semin Respir Med 1983;5:132-140.
4. Grissom CK, Roach RC, Sarnquist FH, Hackett PH: Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange. Ann Intern Med 1992;116:461-465.
5. Sutton JR: Mountain sickness. Neurol Clin 1992;10:1015-1030.
6. Blume FD, Boyer SJ, Braverman LE, Cohen A, Dirkse J, Mordes JP: Impaired osmoregulation at high altitude: studies on Mt. Everest. JAMA 1984;252:524-526.
7. Honigman B, Theis MK, Koziol-McLain J, Roach R, Yip R, Houston C, Moore LG: Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993; 118:587-592.
8. Pugh LGCE: Physiological and medical aspects of the Himalayan scientific and mountaineering expedition, 1960-61. Br Med J 1962;2:621-627.
9. Houston CS: Mountain sickness. Sci Am 1992;267:58-62.
10. Surks MI: Metabolism of human serum albumin in man during acute exposure to high altitude (14,000 ft). J Clin Invest 1966; 45:1442-1452.
11. Hannon JP, Shields JL, Harris CW: Effects of altitude on blood composition in women. J Appl Physiol 1977;26:540-547.
12. Ritschel WA: Pharmacokinetic parameters of important drugs. In, Handbook of Basic Pharmacokinetics. Hamilton, IL: Drug Intelligence Publications, 1992;533.
13. Ritschel WA: AUC-RPP: BASIC computer program for the compartment model independent pharmacokinetic analysis. Methods Find Exp Clin Pharmacol 1986;8:633-640.
14. Ritschel WA: RESID: a curve-fitting program to generate pharmacokinetic parameters. Presented at the International Symposium on Clinical Pharmacokinetics, Salzgitter-Ringelheim, July 20-21, 1975.
15. Ritschel WA: Binding of drugs to biological material. In, Handbook of Basic Pharmacokinetics. Hamilton, IL: Drug Intelligence Publications, 1992;153.
16. Hansen JM, Kanstrup IL, Richalet JP, Olsen NV: High altitude-induced albuminuria in normal man is enhanced by infusion of low-dose dopamine. Scand J Clin Lab Invest 1996;56:367-372.
17. Kamimori GH, Eddington ND, Hoyt RW, Fulco CS, Lugo S, Durkot MJ, et al: Effects of altitude (4300 m) on the pharmacokinetics of caffeine and cardio-green in humans. Eur J Clin Pharmacol 1995;48:167-170.